AGCT1532, A Randomized Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-risk Metastatic Germ Cell Tumors
Phase: Recruiting
Condition(s): Germ Cell Tumor
Other Study ID Number(s): AGCT1532
Who Can Take Part in This Study?
Newly diagnosed patients must have histologic verification of a primary extracranial germ cell tumor in any of the categories outlined in the table below. Elevation of serum tumor markers without histologic confirmation is not sufficient for entry on the trial. Low Risk Stratum (Stage I Ovarian Immature Teratoma and Stage I Malignant GCT (all sites)) patients must be < 50 years of age at enrollment. Standard Risk 1: Patients must be < 11 years of age at enrollment. Standard Risk 2: Patients must be ≥ 11 and < 25 years of age at enrollment.
Principal Investigator
Discover More Research
Explore additional studies relating to germ cell cancers.Your Might Also Be Interested In
Exploring Pediatric Clinical Research
Clinical research involves the study of people, data or tissue samples to understand children’s health and diseases. It’s the foundation for medical advancement and plays a large role in improving health outcomes for children, teenagers and families.
Clinical Research: How We Keep Volunteers Safe
Clinical research is a type of research that involves people. Research participants help researchers to study new types of treatments, like new medicines or medical devices. It might even include changes in how people live or act, such as different ways to eat or exercise.
Stay Updated With Clinical Research. Follow @NCHClinicalResearch on Instagram!
Parents and caregivers can learn more about clinical research on our Instagram channel, @NCHClinicalResearch. You can be part of the clinical research that moves us forward in our journey to best outcomes for all children, everywhere.